Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 1 December 2026
- Last conf. stmt
- 17 November 2025
Emmes Biopharma UK Limited
- Incorporated
- 30 July 2002 (24 years)
- Previously known as
- Orphan Reach Limited (until 5 January 2023)Qed Clinical Services Limited (until 20 July 2018)Monitordirect Limited (until 1 October 2002)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Rama Krishna KondruJohn Matthew Bond
- Controlled by
- Steven Bruce Klinsky
- Accounts type
- Group
- Region
- South East
- Address
- Regus House Fairbourne DriveAtterburyMilton KeynesMK10 9RG
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Kondru, Rama Krishna
Director · Appointed 23 October 2026
American
Born January 1972 (54)
Director · Appointed 21 October 2026
American
Born December 1967 (58)
Bond, John Matthew
Director · Appointed 18 August 2023
American
Born March 1961 (65)
Officer history (17 former)
23 October 2026
Appointed Kondru, Rama Krishna as Director
21 October 2026
1 November 2025
Resigned Ronco, Peter as Director
1 November 2025
Resigned Chilukuri, Sastry Venkata as Director
20 September 2023
Appointed Ronco, Peter as Director
20 September 2023
Appointed Chilukuri, Sastry Venkata as Director
20 September 2023
Resigned Dingivan, Christine as Director
18 August 2023
Appointed Bond, John Matthew as Director
17 August 2023
Resigned Marek, Pavel as Director
15 August 2023
Resigned Van Veldhuisen, Paul as Director
15 August 2023
Resigned Henry, Rhonda Usilton as Director
7 July 2023
Resigned Bang, Debra Glickfield as Secretary
7 July 2023
Resigned Glickfield Bang, Debra as Director
30 June 2023
Resigned Decarlo, Jonathan Paul as Director
22 December 2022
Resigned Ogorka, Thomas as Director
22 December 2022
Resigned Vadodaria, Sheetal as Secretary
22 December 2022
Appointed Bang, Debra Glickfield as Secretary
21 December 2022
Appointed Decarlo, Jonathan Paul as Director
21 December 2022
Appointed Marek, Pavel as Director
21 December 2022
Appointed Van Veldhuisen, Paul as Director
21 December 2022
Appointed Henry, Rhonda Usilton as Director
21 December 2022
Appointed Dingivan, Christine as Director
2 September 2022
Resigned Ogorka, Nazira Khalid as Director
7 March 2022
Appointed Glickfield Bang, Debra as Director
24 September 2014
Resigned Budd, Wendy as Secretary
24 September 2014
Appointed Vadodaria, Sheetal as Secretary
19 February 2014
1 November 2012
Appointed Ogorka, Nazira Khalid as Director
1 March 2012
Appointed Budd, Wendy as Secretary
29 February 2012
Resigned Mangroo, Rajmattie Kumarie as Secretary
15 September 2009
1 April 2008
Appointed Mangroo, Rajmattie Kumarie as Secretary
31 March 2008
Resigned Ogorka, Nazira Khalid as Secretary
30 July 2002
30 July 2002
30 July 2002
Appointed Ogorka, Nazira Khalid as Secretary
30 July 2002
Appointed Ogorka, Thomas as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Steven Bruce Klinsky
Individual · Notified 7 July 2022
Holds 75–100% of voting rights
American
Born May 1956 (70)
Former controllers (3)
7 July 2022
Ceased The Emmes Company, LLC — Owns 75–100% of shares
11 May 2021
Ceased Thomas Ogorka — Owns 75–100% of shares
11 May 2021
Ceased Nazira Ogorka — Has significant influence or control
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £12,784,684
- Cash
- £1,152,919
- Employees
- 31
- Debt Ratio
- 26%
- Current Ratio
- 3.8x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2020 | 2019 | |
|---|---|---|---|---|
| Fixed Assets | £604,827 | £666,279 | £84,806 | £88,187 |
| Current Assets | £16,648,048 | £15,922,645 | £4,844,975 | £2,965,940 |
| Debtors | £15,495,129 | £879,890 | £622,432 | |
| Cash | £1,152,919 | £1,588,173 | £3,770,203 | £2,238,734 |
| Creditors (< 1 year) | £4,393,948 | £4,990,202 | £2,133,926 | £1,958,211 |
| Net Current Assets | £12,254,100 | £10,932,443 | £2,711,049 | £1,007,729 |
| Net Assets | £12,784,684 | £11,524,479 | ||
| Shareholder Funds | £12,784,684 | £11,524,479 | £2,795,855 | £1,095,916 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 31 October 2026 | Appointment of a director | |||
| 30 October 2026 | Appointment of a director | |||
| 16 September 2026 | Compulsory strike-off action has been discontinued | |||
| 15 September 2026 | Confirmation statement with updates | 17 November 2025 | ||
| 14 September 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Cambridge
Cambridge
Oxford
Cambridge
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →